Acorah Software Products - Accounts Production 16.5.460 true true false true No description of principal activity 8 December 2023 31 December 2024 31 December 2024 15336317 Mrs Reem Mohamed Dr Mohammed Shehata iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15336317 2023-12-07 15336317 2024-12-31 15336317 2023-12-08 2024-12-31 15336317 frs-bus:PrivateLimitedCompanyLtd 2023-12-08 2024-12-31 15336317 frs-bus:FilletedAccounts 2023-12-08 2024-12-31 15336317 frs-bus:Micro-entities 2023-12-08 2024-12-31 15336317 frs-bus:EntityHasNeverTraded 2023-12-08 2024-12-31 15336317 frs-bus:AuditExempt-NoAccountantsReport 2023-12-08 2024-12-31 15336317 frs-bus:Director1 2023-12-08 2024-12-31 15336317 frs-bus:Director2 2023-12-08 2024-12-31
Registered number: 15336317
Novel Medical Limited
Unaudited Financial Statements
For the Period 8 December 2023 to 31 December 2024
Novel Medical Limited
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 15336317

| 31 December 2024
--- | ---
|  | £
Current assets |  | 100
NET CURRENT ASSETS |  | 100
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 100
NET ASSETS |  | 100
CAPITAL AND RESERVES |  | 100

## Notes

1. General Information
Novel Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15336317 . The registered office is 1 Duck Meadow, Lyppard Hanford, Worcester, WR4 0HA.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Mohammed Shehata Director
26th August 2025